AI-Driven Strategy: How AI Is Reshaping the Future of Pharma Business Models
Fifteen months ago, pharma leaders were cautiously exploring the potential of Generative AI. Today, AI is no longer an afterthought, it is rapidly becoming the foundation for new business models across life sciences.
This shift was at the heart of a high-impact Fireside Chat hosted by T-Hub, in association with Agilisium. Moderated by Lokesh Bhagchand, Chief Operating Officer at Agilisium, the panel featured industry voices from Regeneron, AWS, Everest Group, and NASSCOM. Together, they unpacked how pharma organizations are evolving from pilots to platforms and from automation to autonomy.
From Use Cases to Strategy
AI has moved beyond isolated experiments. Today, pharma organizations are embedding it across R&D, clinical development, manufacturing, and commercial operations.
Rajiv Onat, India Head, Digital Technology and Engineering at Regeneron, spoke about their enterprise-wide initiative:
Know More About AI-Driven Strategy: How AI Is Reshaping the Future of Pharma Business Models : https://www.agilisium.com/blog....s/redefining-life-sc
